0:000:00
<p>Two great stories of translation science leading to beneficial drugs in terrible diseases of the heart and the Sisyphean task of predicting the need for pacing after TAVI are the topics John Mandrola, MD, discusses in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</p> <p>To read a partial transcript or to comment, visit:</p> <p>https://www.medscape.com/twic</p> <p><strong>I Sotatercept</strong></p> <ul> <li><strong>HYPERION Trial https://www.nejm.org/doi/10.1056/NEJMoa2508170</strong></li> <li><strong>ZENITH Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2415160</strong></li> <li><strong>Evidence report on treatment for PAH https://icer.org/news-insights/press-releases/icer-publishes-final-evidence-report-on-treatment-for-pulmonary-arterial-hypertension/</strong></li> <li><strong>PAH Sotatercept Editorial https://www.nejm.org/doi/full/10.1056/NEJMe2503944</strong></li> </ul> <p><strong>II Acoramidis and ATTR Cardiomyopathy</strong...